SignatureFD’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

SignatureFD’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-870	Closed	-$5.8K	–	3314
2023 Q3	$5.8K	Hold	870	–	–	﹤0.01%	2437
2023 Q2	$7.88K	Buy	+870	New	+$7.67K	﹤0.01%	2336

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

SignatureFD's PNT Position: Q4 2023 in Review

SignatureFD sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 870 shares — an estimated $5.8K sold.

SignatureFD first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $7.88K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

SignatureFD reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
SignatureFD sold 870 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.8K.
SignatureFD first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
SignatureFD's POINT Biopharma Global Inc. Common Stock position peaked at $7.88K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on SignatureFD's 13F filing for Q4 2023, filed 1 Feb 2024.